#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA666394	F	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 2 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	3	ALA1132137	organism-based format	Scientific Literature
2.	ALA691151	F	Minimum cytotoxic concentration against HEL cell morphology.	Homo sapiens	16	ALA1135344	cell-based format	Scientific Literature
3.	ALA690151	F	Cytotoxic concentration reducing HEL cell growth by 50%.	Homo sapiens	16	ALA1135344	cell-based format	Scientific Literature
4.	ALA694172	F	Antiviral activity against the Herpes simplex 1 virus (DNA virus) at a concentration of 2 ug/mL was determined as Plaque forming unit/mL(PFU) by plaque assay; ND-Not determined	Human alphaherpesvirus 1	2	ALA1132137	organism-based format	Scientific Literature
5.	ALA696951	F	Antiviral activity was tested against human cytomegalovirus AD-169 which reduces virus plaque formation by 50%	Human betaherpesvirus 5	14	ALA1135344	organism-based format	Scientific Literature
6.	ALA696953	F	Antiviral activity was tested against human cytomegalovirus Davis which reduces virus plaque formation by 50%	Human betaherpesvirus 5	14	ALA1135344	organism-based format	Scientific Literature
7.	ALA746202	F	Antiviral activity against the Mumps virus (RNA virus) at a concentration of 2 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay; ND-Not determined	Mumps orthorubulavirus	2	ALA1132137	organism-based format	Scientific Literature
8.	ALA746237	F	Antiproliferative activity was tested against murine leukemia cells-L1210/0	Mus musculus	12	ALA1135344	cell-based format	Scientific Literature
9.	ALA812946	F	Antiproliferative activity against human T-lymphocyte cells-CEM/0	Homo sapiens	1	ALA1135344	cell-based format	Scientific Literature
10.	ALA812948	F	Antiproliferative activity was tested against human T-lymphocyte cells-Molt 4/C8	Homo sapiens	12	ALA1135344	cell-based format	Scientific Literature
11.	ALA818213	F	Antiviral activity was tested against TK- Varicella-Zoster virus 07/1 which reduces virus plaque formation by 50%	Human alphaherpesvirus 3	14	ALA1135344	organism-based format	Scientific Literature
12.	ALA818214	F	Antiviral activity was tested against TK+ Varicella-Zoster virus OKA which reduces virus plaque formation by 50%	Human alphaherpesvirus 3	14	ALA1135344	organism-based format	Scientific Literature
13.	ALA818216	F	Antiviral activity was tested against TK+ Varicella-Zoster virus YS which reduces virus plaque formation by 50%	Human alphaherpesvirus 3	14	ALA1135344	organism-based format	Scientific Literature
14.	ALA818220	F	Antiviral activity was tested against TK- Varicella-Zoster virus YS/R which reduces virus plaque formation by 50%	Human alphaherpesvirus 3	14	ALA1135344	organism-based format	Scientific Literature
15.	ALA817792	F	Cytotoxicity on the vero cell culture infected with Coxsackie B5 virus at a concentration of 1 ug/mL was determined as cell viability by the MTT test	Chlorocebus sabaeus	3	ALA1132137	cell-based format	Scientific Literature
16.	ALA817793	F	Cytotoxicity on the vero cell culture infected with Coxsackie B5 virus at a concentration of 2 ug/mL was determined as cell viability by the MTT test	Chlorocebus sabaeus	4	ALA1132137	cell-based format	Scientific Literature
17.	ALA817803	F	Cytotoxicity on the vero cell culture infected with mL and was determined as reduction in protein content by the Lowry test	Chlorocebus sabaeus	3	ALA1132137	cell-based format	Scientific Literature
18.	ALA816210	F	Cytotoxicity on the vero cell culture infected with mL and was determined as reduction in protein content by the Lowry test	Chlorocebus sabaeus	4	ALA1132137	cell-based format	Scientific Literature
19.	ALA821088	F	Antiviral activity against the Vaccinia virus (DNA virus) at a concentration of 2 ug/mL was determined as Plaque forming unit/mL(PFU) by plaque assay; ND-Not determined	Vaccinia virus	2	ALA1132137	organism-based format	Scientific Literature